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Inactivity on the kidney transplant wait-list
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transplant outcomes.
Abstract: Background: The majority of kidney transplant (KT)
candidates spend some time on the transplant wait-list (WL) prior to
kidney transplantation. We examined the impact of WL inactivity on
clinical outcomes.
Methods: All adult KT candidates ﬁrst actively wait-listed between
January 1, 1996, and December 31, 2005, in the United States were
grouped by frequency of inactivity on the WL. Transplantation rate, pre-
and post-transplant patient survival and death-censored kidney graft
survival were compared.
Results: Of 159 774 candidates who were placed on the WL, 48 598
(30.4%) experienced one or more periods of inactivity. Candidates with
inactivity once or more on the WL had 42% and 27% less likelihood of
KT, respectively (HR 0.58, 95% CI 0.57, 0.59 and HR 0.73, 95% CI 0.71,
0.75). WL inactivity once or more was associated with a higher likelihood
of death (HR 1.94, 95% CI 1.88, 2.00 and HR 2.13, 95% CI 2.02, 2.24).
Among KT recipients, inactivity more than once on the WL was
associated with a higher risk of death (HR 1.14, 95% CI 1.05, 1.23).
Conclusions: Periods of inactivity on the WL predict increased mortality
pre- and post-transplantation. A better understanding of the reasons for
WL inactivity is essential to improve WL management and post-
transplant outcomes.
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Kidney transplantation is the best treatment
modality for qualiﬁed patients with end-stage renal
disease (ESRD) and is associated with improved
patient survival and quality of life compared with
dialysis (1, 2). There are several steps involved to
receive a kidney transplant (KT) including patient
referral, evaluation and wait-listing for transplan-
tation. Previous studies have examined the factors
that aﬀect likelihood of transplant evaluation
referral, completion of evaluation, and wait-listing
(3, 4). Demographic diﬀerences in race and gender,
and socioeconomic status have been consistently
highlighted as factors among others that lead to
diﬀerential access to be placed on the wait-list
(WL; 4–7). Less attention has been paid to the
impact of events that occur during wait-listing per-
iod on patient outcomes, despite the long period of
time that qualiﬁed candidates often spend on the
WL.
Once on the WL, the candidates can remain
“active” (status 1 in UNETsm) with the possibility
of receiving a KT when an organ becomes avail-
able, or be temporarily “inactive” (status 7) which
makes them ineligible to receive a KT. A candidate
may change from active to inactive status several
times prior to successful transplantation. Candi-
dates are ultimately removed from the WL for one
of three reasons: transplant, death, or delisting.
While practices vary among the diﬀerent transplant
programs, the placement of a previously active can-
didate into an inactive status typically reﬂects a
medical or non-medical acute event that makes the
candidate temporarily inappropriate for transplan-
tation with the expectation that the candidate will
be appropriate for transplant once the acute event
resolves. The prevalence of “inactive” candidates in
a given year has been increasing in recent years
likely reﬂecting an increase in overall medical
co-morbidities (8). How inactive status on the WL
impacts clinical outcomes before and after kidney
transplantation remains unclear. We hypothesized
that the transition from the active to inactive status
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on the WL may be a surrogate marker for overall
medical co-morbidity and/or complexity. We inves-
tigated the eﬀect of WL inactivity on the clinical
outcomes pre- and post-transplantation in a
national cohort of wait-listed KT candidates.
Materials and methods
Using a US national transplant database provided
by the Organ Procurement and Transplantation
Network (OPTN)/Scientiﬁc Registry of Transplant
Recipients (SRTR), we identiﬁed all adult
(age ≥ 18) KT candidates who were ﬁrst time
actively wait-listed between January 1, 1996, and
December 31, 2005. Study follow-up continued
until January 31, 2010. The SRTR data system
includes data on all donors, wait-listed candidates,
and transplant recipients in the United States, sub-
mitted by the members of the OPTN, and has been
described elsewhere (9). The Health Resources and
Services Administration (HRSA), US Department
of Health and Human Services, provides oversight
to the activities of the OPTN/SRTR contractors.
For each candidate, we determined whether during
the wait-listing period he or she ever had a change
from active (status 1) to inactive status (status 7),
and if so, how many times. We separated the study
population into three groups: (i) active – never
inactivated; (ii) inactivated once; and (iii) inacti-
vated more than once on the WL. We excluded
candidates who never had been active on the WL,
listed for and/or received multi-organ transplants,
repeat KT, and candidates and patients with miss-
ing wait-listing and/or subsequent transplant out-
come information. The primary outcomes of the
study were the rate of kidney transplantation, mor-
tality on the WL, and death-censored post-trans-
plant kidney graft and recipient survival.
Baseline demographics of the study groups were
compared using chi-square test and ANOVA, as
appropriate. An unadjusted Poisson regression
model was utilized to compare the incidence rate
of receiving a KT, living and/or deceased, among
the three groups on the WL taking into consider-
ation the total time spent on the WL. Kaplan–Me-
ier methods with log-rank test were used to
estimate kidney graft and recipient survival follow-
ing kidney transplantation. Two sets of Cox pro-
portional hazard models were applied for clinical
outcomes before and after kidney transplantation.
For the primary outcomes of time to transplanta-
tion, censored for delisting and death, and time to
the WL death, censored for delisting and trans-
plantation, the time at risk began when candidates
were actively wait-listed for the ﬁrst-time with
wait-listing inactivity as a two-tier time-dependent
covariate. As some candidates started out as inac-
tive on the WL and subsequently moved to active
status, the time interval between these two was cal-
culated and used as one of the covariates in the
multivariate analyses as well. For kidney graft and
recipient survival analyses, the time at risk began
with the transplantation. The demographic and
baseline variables at the time of active listing and
transplantation were used for multivariate
analyses, respectively. The interaction term was
considered and tested wherever appropriate in
multivariate analyses for pre- and post-transplant
mortality risk. Final models contain those vari-
ables with p < 0.10 after backward selection.
Analyses were run in SAS 9.2 (SAS Institute
Inc., Cary, NC, USA), with statistical signiﬁcance
set at a two-sided a = 0.05. The procedures of our
study were in accordance with the Helsinki Decla-
ration of 1975.
Results
During the study period, a total of 163 802 candi-
dates were actively wait-listed for a ﬁrst-time KT.
After excluding multi-organ transplant candidates
and/or recipients (n = 3686), candidates who had
missing follow-up information (n = 331), and
candidates erroneously identiﬁed as having died
and then subsequently relisted (n = 11), there were
159 774 candidates available for analysis. The
mean age of wait-listed candidates was 49.7
 13.0 yr. African Americans (AA) accounted for
29.6% (47 240) and males for 59.4% (94 904) of
the study population. Among all WL candidates,
37 823 (23.7%) experienced one and 10 775
(6.7%) candidates experienced more than one per-
iod of WL inactivity. Demographic characteristics
of the study population are shown in Table 1. In
general, the candidates who had been placed on
inactive status at least once while on the WL
tended to be older, heavier, and more likely AA.
Inactivated candidates were less often college-edu-
cated and experienced longer dialysis times and
were more likely to be sensitized. Furthermore,
candidates who experienced inactivity displayed
more medical co-morbidities such as diabetes mell-
itus (DM) and cardiovascular disease (CVD).
The distribution of study outcomes among can-
didates in the three groups at the end of study
follow-up are shown in Fig. 1. In the univariate
analysis, compared with candidates never inacti-
vated on the WL, the overall transplantation rate
was signiﬁcantly lower for candidates who were
inactive either once or more than once (407.8
 3.3, 101.9  2.0 and 90.2  3.1 transplants per
1000 patient-years, respectively, p < 0.001 for both
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comparisons; Fig. 2). Inactivity negatively
impacted transplant rates of both living and
deceased donor KT. The eﬀect of inactivity per-
sisted even when only active time was considered
to calculate transplant rates (data not shown).
Multivariate Cox regression analyses with WL
inactivity as a time-dependent variable showed that
inactivity once or more than once while on the WL
was associated with 42% and 27% lower likeli-
hood of receiving a KT (HR 0.58, 95% CI 0.57,
0.59, p < 0.001, and HR 0.73, 95% CI 0.71, 0.75,
p < 0.001, respectively). Other variables indepen-
dently associated with the low likelihood of kidney
transplantation included AA race (HR 0.50, 95%
CI 0.49, 0.51, p < 0.001), medical co-morbidities
such as DM (HR 0.83, 95% CI 0.82, 0.84,
p < 0.001) or CVD (HR 0.92, 95% CI 0.91, 0.94,
p < 0.001), lower education levels (p < 0.001), and
longer dialysis time (p < 0.001) (Table 2). In con-
trast, PRA level >80 (HR 1.20, 95% CI 1.15, 1.26,
p < 0.001) and having a private insurance (HR
1.20, 95% CI 1.19, 1.22, p < 0.001) were associated
with higher likelihood of receiving kidney trans-
plantation.
We further analyzed mortality risk for all candi-
dates on the WL according to their history of inac-
tive status following the initial active listing, again
using WL inactivity as a two-tier time-dependent
variable. Compared with the candidates who were
never placed in inactive status, the risk of WL
death was 94% higher in candidates inactivated
once (HR 1.94, 95% CI 1.88, 2.00, p < 0.001) and
113% higher in candidates inactivated more than
once (HR 2.13, 95% CI 2.02, 2.24, p < 0.001). The
high mortality risk was primarily contributed by
death during inactive periods in the later follow-up
Table 1. Demographic and baseline char-
acteristics of wait-list candidates Never inactive
N = 111 176
Inactive once
N = 37 823
Inactive > once
N = 10 775 p
Age, mean (SD) 49.3 (13.2) 50.8 (12.7) 50.2 (12.5) <0.001
African American, n (%) 30 525 (27.5) 13 138 (34.7) 3577 (33.2) <0.001
Male, n (%) 66 340 (59.7) 22 298 (59.0) 6266 (58.2) 0.001
BMI*, mean (SD) 27.3 (5.4) 28.6 (6.7) 28.6 (6.4) <0.001
Education, n (%) <0.001
Less than high school 7607 (6.8) 2943 (7.8) 757 (7.0)
High school 55 595 (50.0) 20 356 (53.8) 5605 (52.0)
College or higher 47 974 (43.2) 14 524 (38.4) 4413 (41.0)
Private insurance, n (%) 52 211 (47.0) 15 230 (40.3) 4717 (43.8) <0.001
On dialysis, n (%) 46 840 (42.1) 21 488 (56.8) 6289 (58.4) <0.001
Dialysis duration, yr (SD) 0.7 (1.7) 1.1 (2.1) 1.0 (1.8) <0.001
PRA, n (%) <0.001
<10 89 508 (80.5) 31 314 (82.8) 8895 (82.6)
10–80 17 099 (15.4) 4196 (11.1) 1314 (12.2)
>80 4569 (4.1) 2313 (6.1) 566 (5.3)
Diabetes mellitus, n (%) 39 250 (35.3) 15 696 (41.5) 4281 (39.7) <0.001
Cardiovascular disease, n (%) 16 466 (14.8) 6676 (17.7) 1888 (17.5) <0.001
Blood transfusion 45 411 (40.8) 16 416 (43.4) 4834 (44.9) <0.001
*BMI = body mass index, kg/m2.
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Fig. 1. Clinical outcome distribution
among study group candidates.
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period (data not shown). DM (HR 1.86, 95% CI
1.81, 1.91, p < 0.001), a history of CVD (HR 1.34,
95% CI 1.31, 1.38, p < 0.001), blood transfusion
(HR 1.16, 95% CI 1.13, 1.19, p < 0.001), and dial-
ysis time longer than three yr (HR 1.34, 95% 1.24,
1.44, p < 0.001) were independently associated
with a higher risk of WL death. In contrast, AA
race (HR 0.82, 95% CI 0.80, 0.85, p < 0.001), a
lower level of education (HR 0.75, 95% CI 0.71,
0.78, p < 0.001), and having private insurance (HR
0.83, 95% CI 0.81, 0.86, p < 0.001) appeared asso-
ciated with a lower risk for WL death (Table 3).
Among 102 340 WL candidates who received a
KT during the study period, 83 284 (81.3%) never
experienced inactivity and waited a median of
1.1 yr (0.4, 2.4). A total of 14 589 (14.3%) experi-
enced one inactive period and 4467 (4.4%) more
than one inactive period on the WL, with median
times to KT of 2.7 (1.4, 4.2) and 3.6 (2.4, 5.0) yr,
respectively. Signiﬁcant diﬀerences in many of
demographic and baselines variables were again
observed among patients of three groups which
appeared to favor patients who never experienced
WL inactivity (supplementary table). After exclud-
ing transplant recipients with missing follow-up
information (n = 1038), death-censored kidney
graft survival was similar among the three groups
during the follow-up by Kaplan–Meier estimate
(log-rank p = 0.307; Fig. 3), which was conﬁrmed
in multivariate Cox regression analyses (data not
shown). Patient survival, however, appeared
inferior among candidates who had experienced
more than one period of WL inactivity compared
with those who were never inactive (log-rank,
p < 0.001; Fig. 4). Speciﬁcally, the mortality risk
for KT recipients with a history of WL inactivity
more than once compared with never inactive
recipients was signiﬁcantly higher (HR 1.14, 95%
CI 1.05, 1.23, p = 0.001). In addition, old age (HR
1.04, 95% CI 1.04, 1.04, p < 0.001), a history of
DM (HR 1.74, 95% CI 1.69, 1.78, p < 0.001), and
a history of CVD (HR 1.33, 95% CI 1.29, 1.38,
p < 0.001) were associated with higher post-trans-
plant mortality (Table 4).
Not surprisingly, at the end of study follow-up,
a smaller proportion of WL candidates from the
never inactive group remained either waiting for
KT or experienced delisting compared WL candi-
dates with a history of inactivity during the WL
period.
Discussion
Periods of WL inactivity are typically conceived as
a response to acute events that have resolved when
the candidate is reactivated. However, there
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Fig. 2. Transplantation rates among
study group candidates.
Table 2. Factors associated with the likelihood of kidney transplan-
tation
Variables Hazard Ratio 95% CI p
Wait-list inactivity <0.001
Never inactive Ref. Ref. Ref.
Inactive once 0.58 0.57, 0.59 <0.001
Inactive > once 0.73 0.71, 0.75 <0.001
Race: African American 0.50 0.49, 0.51 <0.001
BMI, kg/m2 0.99 0.98, 0.99 <0.001
Education <0.001
Less than high school 0.80 0.78, 0.82 <0.001
High school 0.88 0.87, 0.90 <0.001
College or higher Ref. Ref. Ref.
Diabetes mellitus, yes 0.83 0.82, 0.84 <0.001
Cardiovascular disease, yes 0.92 0.91, 0.94 <0.001
History of blood transfusion,
yes
0.94 0.93, 0.96 <0.001
Dialysis history <0.001
No dialysis Ref. Ref. Ref.
<1 yr 0.97 0.95, 0.98 0.001
1–3 yr 0.83 0.81, 0.84 <0.001
>3 yr 0.76 0.74, 0.78 <0.001
PRA <0.001
<10 Ref. Ref. Ref.
10–80 1.02 0.99, 1.05 <0.001
>80 1.20 1.15, 1.26 <0.001
Private insurance, yes 1.20 1.19, 1.22 <0.001
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appears to be a persistent impact of inactive epi-
sodes. We found that inactive status was associated
with lower transplantation rate and higher mortal-
ity on the WL. Furthermore, even among patients
who ultimately received a KT, a prior history of
repeated inactivity on the WL predicted higher
post-transplant mortality. A previous study by
Delmonico and McBride described high rate of
death among candidates in inactive status although
they did not provide detail on how often those can-
didates were active during wait-listing and did not
compare inactive to active candidates (8). Our ﬁnd-
ings suggest that in candidates who were initially
suitable for active listing, subsequent periods of
inactive status are associated with an increased
mortality risk, with most death occurring during
the periods of inactivity. Thus, inactive status
appears to be a surrogate for risk factors, particu-
larly CVD risks that are not adequately captured
by current transplant evaluation or WL screenings.
Our ﬁndings are consistent with a number of stud-
ies that have highlighted the inadequacy of current
screening techniques to adequately stratify the
CVD risk in KT candidates (10–12). Further inves-
tigation into the reasons for candidates being
placed in inactive status may help explain the
observed mortality and prevent the events leading
to WL inactivity and/or death.
We observed more pre-emptive listing, shorter
dialysis times, and subsequently more pre-emptive
Table 3. Factors associated with wait-list mortality
Variables Hazard ratio 95% CI p
Wait-list inactivity <0.001
Active Ref. Ref. Ref.
Inactive 1 1.94 1.88, 2.00 <0.001
Inactive > 1 2.13 2.02, 2.24 <0.001
Time between listing and
first activation, month
1.01 1.01, 1.02 <0.001
Age, yr 1.03 1.02, 1.03 <0.001
Race: African American 0.82 0.80, 0.85 <0.001
BMI, kg/m2 0.99 0.98, 0.99 <0.001
Education <0.001
Less than high school 0.75 0.71, 0.78 <0.001
High school 1.04 1.01, 1.06 0.008
College or higher Ref. Ref. Ref.
Private insurance, yes 0.83 0.81, 0.86 <0.001
Diabetes mellitus, yes 1.86 1.81, 1.91 <0.001
Cardiovascular disease,
yes
1.34 1.31, 1.38 <0.001
History of blood
transfusion, yes
1.16 1.13, 1.19 <0.001
Dialysis history <0.001
None Ref. Ref. Ref.
<1 yr 0.92 0.87, 0.97 0.001
1–3 yr 0.99 0.94, 1.04 0.653
>3 yr 1.34 1.24, 1.44 <0.001
PRA <0.001
<10 Ref. Ref. Ref.
10–80 1.65 1.57, 1.74 <0.001
>80 1.93 1.78, 2.08 <0.001
Table 4. Factors associated with post-transplant mortality risk
Variables Hazard ratio 95% CI p
Wait-list inactivity <0.001
Active Ref. Ref. Ref.
Inactive 1 1.02 0.98, 1.06 0.414
Inactive > 1 1.14 1.05, 1.23 0.001
Age, yr 1.04 1.04, 1.04 <0.001
Gender: Male 1.07 1.04, 1.10 <0.001
Education <0.001
Less than high school 0.96 0.91, 1.02 0.148
High school 1.10 1.07, 1.13 <0.001
College or higher Ref. Ref. Ref.
Diabetes mellitus, yes 1.74 1.69, 1.78 <0.001
Cardiovascular disease, yes 1.33 1.29, 1.38 <0.001
History of blood transfusion,
yes
1.16 1.13, 1.19 <0.001
Fig. 3. Death-censored kidney graft survival following kidney
transplantation in patients with and without a history of wait-
list inactivity. Log-rank p = 0.307.
Fig. 4. Recipient survival following kidney transplantation
in patients with and without a history of wait-list inactivity
Log-rank p < 0.001.
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KT among candidates who were never inactive on
the WL. Less exposure to dialysis may be one of
the reasons for less WL inactivity and better post-
transplant survivals. Previous studies have docu-
mented the beneﬁts of pre-emptive transplantation
on kidney and recipient survival (13–15). In fact,
one recent study showed that the negative impact
of end-stage kidney disease on post-transplanta-
tion outcomes was mainly an eﬀect of dialysis
duration prior to wait-listing (16). Thus, our cur-
rent ﬁndings were consistent with the above obser-
vations and reinforce the importance of early
access to the WL and to transplantation for opti-
mal outcomes.
Higher transplantation rate for candidates from
the active group was not only limited to deceased
donor KT. In fact, substantially more live donor
transplants were also performed among candidates
in the never inactive group. The reasons for more
live donor transplants are not readily apparent
from the WL demographics. Clearly, there are fac-
tors present in the active group or missing in the
inactive groups that increase the likelihood of live
donor transplantation. These factors, not captured
by the use of current national registry data, could
include diﬀerences in economic/income status,
family structure, and social support, and even the
extent of pre-ESRD/pre-listing care from a special-
ist (17–19). Whether the lower transplantation rate
and high mortality among candidates in the inac-
tive groups on the WL are actual consequence of
demographic diﬀerences remains unclear. Elucidat-
ing the reasons behind the WL inactivity may
prove very important to WL management and ulti-
mately transplant outcomes.
The strongest predictor for WL mortality was
experiencing inactivity independent of other base-
line variables including reported medical co-mor-
bidities such as DM and CVD. Based on our
current observations, we would argue for the
need of dedicated attention paid by the trans-
plant programs/providers to WL candidates who
are placed in inactive status to understand the
reasons leading to such inactivity and to maxi-
mize medical health while on the WL. A ﬁrst
inactive event may provide an opportunity to
reevaluate a candidate’s health status and to
ensure the optimal WL management of that par-
ticular candidate.
Our study has several limitations. First, it is a
retrospective registry study, and as such we are
limited from making any causal claims of observed
association between WL inactivity and pre- and
post-transplant outcomes. Second, the lack of
granularity in the registry data utilized limits our
ability to fully understand the reasons behind
events leading to WL inactivity and/or delisting,
even when an apparent reason is listed. Third, indi-
vidual-level variables such as income, family struc-
ture and/or social support, and existence of pre-
ESRD/pre-listing care, clearly important to overall
patient outcomes, are not available; thus, their
contribution to WL inactivity remain unknown.
Finally, some transplant programs routinely place
all transplant candidates on the WL initially in
inactive status in order for candidates to accrue the
waiting time, while the transplant evaluation is
being completed. By including only candidates
who had experienced at least one period of activity,
we may eliminated from analysis a cohort of candi-
dates who might never be suitable to kidney trans-
plantation, biasing our results.
In conclusion, WL inactive status appears to be
a surrogate for medical and perhaps socioeco-
nomic co-morbidities and was associated with a
decreased transplant opportunity and an increased
risk of WL and post-transplant death. Increased
attention should be paid by transplant programs
and providers to candidates who require periods of
inactivity. A better understanding of the factors
associated with inactive status may improve risk
stratiﬁcation, WL management, and ultimately
pre- and post-transplant survival.
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